Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

T Cell Response in Hypersensitivity Syndrome

This study has been completed.
Information provided by (Responsible Party):
University Hospital, Rouen Identifier:
First received: September 13, 2005
Last updated: June 17, 2013
Last verified: June 2013
immunological study of the T cell repertoire phenotype and functionality in hypersensitivity syndrome.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Characterization of T Cell Response in Hypersensitivity Syndrome

Resource links provided by NLM:

Further study details as provided by University Hospital, Rouen:

Estimated Enrollment: 40
Study Start Date: November 2002
Estimated Study Completion Date: December 2005

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with Drug rash with eosinophilia and systemic symptoms

Inclusion Criteria:

  • age > 18
  • cutaneous eruption
  • lymph nodes
  • hepatitis
  • interstitial pneumonia
  • nephritis
  • cardiopathy
  • eosinophilia
  • hyperlymphocytosis

Exclusion Criteria:

  • age minor to 18
  • HIV +
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00213447

Rouen, France
Sponsors and Collaborators
University Hospital, Rouen
Principal Investigator: Pascal Joly, MD-PHD UH rouen
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: University Hospital, Rouen Identifier: NCT00213447     History of Changes
Other Study ID Numbers: 2001/056/HP 
Study First Received: September 13, 2005
Last Updated: June 17, 2013
Health Authority: France: Ministry of Health

Additional relevant MeSH terms:
Drug Hypersensitivity Syndrome
Pathologic Processes
Immune System Diseases
Drug Eruptions
Skin Diseases
Drug Hypersensitivity
Drug-Related Side Effects and Adverse Reactions
Chemically-Induced Disorders processed this record on October 28, 2016